Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3303672015 | Parenteral form insulin aspart + insulin degludec (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3303673013 | Parenteral form insulin aspart + insulin degludec | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3658878018 | Product containing insulin aspart and insulin degludec in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3658879014 | Insulin aspart and insulin degludec in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3658880012 | Product containing insulin aspart and insulin degludec in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3710421016 | Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3710422011 | Insulin aspart- and insulin degludec-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 108473201000001115 | Parenteral form insulin aspart + insulin degludec | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Is a | Product containing insulin aspart and insulin degludec | true | Inferred relationship | Existential restriction modifier | ||
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Is a | Product containing insulin degludec in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Has active ingredient | Insulin aspart | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Has active ingredient | Insulin degludec | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Is a | Product containing insulin aspart in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Is a | True | Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR